Cargando…
Residual serum fibrinogen as a universal biomarker for all serotypes of Myasthenia gravis
Myasthenia Gravis (MG) is an autoimmune disease associated with severe neuromuscular weakness. Diagnostic confirmation of MG is typically delayed and secured in about 85% and 50% of patients with generalized and ocular MG, respectively with serum antibodies. We have identified a sensitive and specif...
Autores principales: | Hussain, Faraz S., Piragasam, Ramanaguru S., Sarker, Hassan, Blackmore, Derrick, Yacyshyn, Elaine, Fernandez-Patron, Carlos, Fahlman, Richard P., Siddiqi, Zaeem A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10692328/ https://www.ncbi.nlm.nih.gov/pubmed/38040826 http://dx.doi.org/10.1038/s41598-023-47559-x |
Ejemplares similares
-
Guillain Barré syndrome and COVID-19: Possible role of the cytokine storm
por: Hussain, Faraz S., et al.
Publicado: (2020) -
Pharmacodynamic Properties of Subcutaneous Immunoglobulin in Myasthenia Gravis: Sub-analyses From an Open-Label Trial
por: Putko, Brendan N., et al.
Publicado: (2020) -
Rituximab in refractory myasthenia gravis: a prospective, open‐label study with long‐term follow‐up
por: Anderson, Dustin, et al.
Publicado: (2016) -
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
por: Townsel, Courtney, et al.
Publicado: (2016) -
Myasthenia gravis and preeclampsia: Dot all the I's and cross all the T's
por: Hassan, Ali
Publicado: (2017)